Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1214

2.

Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.

Wilmer M, Stocker C, Bühler B, Conell B, Calatzis A.

Am J Clin Pathol. 2004 Dec;122(6):836-42.

PMID:
15539375
3.
4.
5.

The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.

de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.

Thromb Haemost. 2000 Apr;83(4):577-82.

PMID:
10780320
7.

Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.

Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.

Thromb Haemost. 2001 Sep;86(3):800-3.

PMID:
11583310
8.
9.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
10.

Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.

Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J.

Thromb Haemost. 2002 Jul;88(1):5-11.

PMID:
12152677
11.

Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.

Chaireti R, Jennersjö C, Lindahl TL.

Thromb Res. 2009 Jun;124(2):178-84. doi: 10.1016/j.thromres.2008.12.033. Epub 2009 Feb 20.

PMID:
19232683
12.

Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.

Graf LL, Welsh CH, Qamar Z, Marlar RA.

Am J Clin Pathol. 2003 Jan;119(1):52-60.

PMID:
12520697
14.

Laboratory diagnosis of hereditary thrombophilia.

Michiels JJ, Hamulyák K.

Semin Thromb Hemost. 1998;24(4):309-20. Review.

PMID:
9763348
15.

[Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].

Ehrenforth S, Klinke S, von Depka Prondzinski M, Kreuz W, Ganser A, Scharrer I.

Dtsch Med Wochenschr. 1999 Jun 25;124(25-26):783-7. German.

PMID:
10414227
16.

Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.

Brugge JM, Simioni P, Bernardi F, Tormene D, Lunghi B, Tans G, Pagnan A, Rosing J, Castoldi E.

J Thromb Haemost. 2005 Dec;3(12):2695-702.

17.

The response to activated protein C after cardiopulmonary bypass: impact of factor V leiden.

Donahue BS.

Anesth Analg. 2004 Dec;99(6):1598-603, table of contents.

PMID:
15562039
18.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

PMID:
20368522
19.

Evaluation of a highly specific functional test for the detection of factor V Leiden.

Quenhenberger P, Handler S, Mannhalter C, Pabinger-Fasching I, Speiser W.

Int J Clin Lab Res. 2000;30(3):113-7.

PMID:
11196068
20.

Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?

Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.

Thromb Haemost. 1997 Dec;78(6):1480-3.

PMID:
9423798

Supplemental Content

Support Center